close read more

Servier accelerates its digital transformation


Servier accelerates its digital transformation

Convinced of the strategic stakes represented by the digitalization of its activities, the Servier Group has initiated an ambitious digital transformation.

It focuses on several fundamental axes: The overhaul of the Group’s IT infrastructures; the implementation of a new global data governance system; The development of a state-of-the-art “Group data platform” and the implementation of agile teams working on artificial intelligence initiatives; The development of a process automation platform.

As part of its transformation, Servier has created a new department designed to steer the digital strategy of the Group: Digital, Data, and Information Systems Department.

To accompany this transformation, Virginie Dominguez has joined the Group in 2020 as Chief Digital Officer. As the head of the new department, she is in charge of the Group’s digital strategy and leads an internal team of 200 people with a wide range of expertise, such as data scientists, data engineers, and product owners.


Virginie Dominguez, Graduate of the Ecole Polytechnique and the Ecole des Ponts et Chaussées, has more than fifteen years of expertise in the digital field, developed within the Orange Group. “This transformation will fully contribute to the Group’s sustainability and independence by making our organization even more efficient”, announce Virginie. “Digital opens up fantastic opportunities for the benefit of patients and health care professionals, in the discovery of new medicines, as well as in prevention, diagnosis, and also adherence to treatments.”


For Olivier Laureau, President of Servier: ‟Servier has embarked on a profound digital transformation. I am convinced that this is an indispensable lever for the Group’s development and performance. Virginie Dominguez will play a major role in this transformation and her solid experience will allow us to accelerate the transformation of the Group to better serve our vocation: committed to therapeutic progress to serve patient needs.”


Read the press release

Last news

Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting!
Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader
Patient associations’ perception of pharmaceutical companies: Servier is making progress!